ReVision Therapeutics
San Diego · Founded 2010
About ReVision Therapeutics
ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. Its product includes Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in 2010 and is based in San Diego, California.
Company Facts
- Founded: 2010
- Legal name: ReVision Therapeutics, Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.4M
- Last round: Series Unknown (Dec 2011)
- Website: revisiontherapeutics.com
- Phone: +1 858-768-7860
Canonical: https://fsome.com/organization/revision-therapeutics-8394793 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.